<DOC>
	<DOC>NCT01386671</DOC>
	<brief_summary>The aim of this study is to compare the efficacy and safety of Metformin Glycinate versus Metformin Hydrochloride in metabolic control and inflammatory mediators in Mexican drug naïve type 2 diabetes patients, in a 12 months follow up.</brief_summary>
	<brief_title>Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes according ADA Less than a year of evolution since diagnosis Antihyperglycemic pharmacological treatment HbA1c between 7.1% and 9.0% Stable weight during the last 6 months Body Mass Index ≥ 25 kg/m2 and &lt;35kg/m2. Blood pressure ≤ 130/80 mmHg Childbearing women under contraceptive treatment Signed Informed Consent Form Age from 18 to 70 years old Nonfulfilment treatment in the screening period Drugs or alcohol abuse Creatinine depuration estimated with MDRD formula using serum creatinine &lt; 90 ml/min/1.72m2 History of chronic liver disease, ALT or AST ≥ 2 times from the normal superior limit, or GGT ≥ 3 times from the normal superior limit. Chronic lung disease, that causes dyspnea equivalent to a functional class ≥3 (NYHA)or that requires oxygen supplementation. History or symptoms of coronary artery disease (CAD) or cerebrovascular disease (CVD). Drug treatment that interact with biguanides. Another chronic diseases that restricts survival or associated with chronic inflammation like: cancer, leukemia, lymphoma, erythematosus lupus, asthma, rheumatoid arthritis or infection for HIV. Pregnancy or positive pregnancy test in women under 50 years old or breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>metformin glycinate</keyword>
	<keyword>metabolic control</keyword>
</DOC>